1-3 of 3
Xinli Pang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CD47-Blocking Immune Checkpoint Inhibitor Maplirpacept Does Not Interfere with Blood Transfusion Compatibility Testing

Mithunah Krishnamoorthy, Natasja N. Viller, Mark Wong, Karen Dodge, Xinli Pang, Robert A. Uger, Gloria H.Y. Lin, Megan M. Kaneda
Journal: Blood
Blood (2023) 142 (Supplement 1): 4037.
https://doi.org/10.1182/blood-2023-174949
Published: 2023
Journal Articles

SIRPαFc, a CD47-Blocking Cancer Immunotherapeutic, Sensitizes Malignant B Cells to Macrophage-Mediated Destruction

Natasja Nielsen Viller, Saman Maleki Vareki, Karen Dodge, Hui Chen, Vivian Lee, Vien Chai, Xinli Pang, Mark Wong, Suzanne Trudel, MD, Rene Figueredo, Macarena Pampillo, James Koropatnick, Penka S. Petrova, Robert A. Uger
Journal: Blood
Blood (2015) 126 (23): 2191.
https://doi.org/10.1182/blood.V126.23.2191.2191
Published: 2015
Journal Articles

Blockade Of CD47 Using SIRPαFc: Role Of The Fc Region In Anti-Leukemic Activity and Tolerability

Robert A. Uger, PhD, Xinli Pang, MD, PhD, Mark Wong, PhD, Violetta House, Karen Dodge, Stephane Viau, Noel T. Vigo, Debbie Tam, Tran Truong, Liqing Jin, MD, Andrei V. Malko, Jenny Ho, MD, Tatiana K. Prasolava, PhD, Jayne S. Danska, PhD, Jean C.Y. Wang, MD PhD, Penka S. Petrova, PhD
Journal: Blood
Blood (2013) 122 (21): 3935.
https://doi.org/10.1182/blood.V122.21.3935.3935
Published: 2013